HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
4- chloro- 3- (6- (5- (2- hydroxypropan- 2- yl)- 1H- 1,3- benzodiazol- 1- yl)pyridin- 2- yl)benzonitrile
a positive allosteric modulator of GABA-A receptors; structure in first source
Also Known As:
NS16085
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Pyridines: 88
4-chloro-3-(6-(5-(2-hydroxypropan-2-yl)-1H-1,3-benzodiazol-1-yl)pyridin-2-yl)benzonitrile: 1
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Benzimidazoles: 245
4-chloro-3-(6-(5-(2-hydroxypropan-2-yl)-1H-1,3-benzodiazol-1-yl)pyridin-2-yl)benzonitrile: 1
Experts
1.
Amrutkar, Dipak V
: 1 article (04/2020)
2.
Dyhring, Tino
: 1 article (04/2020)
3.
Jacobsen, Thomas A
: 1 article (04/2020)
4.
Larsen, Janus S
: 1 article (04/2020)
5.
Sandager-Nielsen, Karin
: 1 article (04/2020)
Related Diseases
1.
Tremor (Tremors)
04/01/2020 - "
We show that the GABAA α2/3 subtype selective modulator NS16085 significantly and dose-dependently inhibits harmaline-induced tremors in rats, indicating that potentiation of α2- and α3-containing GABAA receptors is sufficient to ameliorate harmaline-induced tremors.
"
Related Drugs and Biologics
1.
Harmaline